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steroid administration, Drotrecogin Alfa administration, and gly-
cemic control goal. Outcome measures were; In-hospital mortal-
ity, ICU mortality, ICU LOS, hospital LOS and hospital discharge
location. RESULTS: Of 58 patients, 24 (41%) met the criteria for
severe sepsis with an average APACHE III score of 69  31. There
was a score of 60% on four (50%) of the eight process measures
and <35%on the other four. In-hospital mortality of 25% (16.7%
for ICU) compared favorably with 28.6% national. Average
hospital LOS (9.1  6.5 days) and ICU LOS (3.3  3.4 days)
were within expected benchmarks. Discharge to skilled nursing
facility was 21%. Compared to those who did not meet severe
sepsis criteria, the mortality rates were lower (25% vs. 29.1%)
and the LOS values higher (9.1 vs. 8.4 days) in the severe sepsis
group. The average direct cost of severe sepsis hospitalization was
$30,061, mean daily cost of $3303. CONCLUSIONS: Variation
in adoption of the SSC-IHI guideline is apparent. Though, severe
sepsis outcomes are above average, opportunities for process
improvement that should enhance outcomes in this setting exist.
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OBJECTIVES: Antibacterial agents are still overused in many
developing countries with the main consequence of constant
increase in bacterial resistance. The purpose of this study is to
compare the utilization of antibacterial agents and its economic
impact on two leading University Hospitals in two neighboring
countries, Croatia and Bosnia and Herzegovina, having similar
historical values, but now having notable differences in health
care system and GDP. Secondary objective was to assess the
appropriateness of clinical guidelines and level of their imple-
mentation in each hospital. METHODS: Antibacterial utilization
in 2007 was assessed for each hospital using the ABC calculator
version 3.1. The results were compared at ATC levels 2–4. The
following calculated parameters were used for the adjusted hos-
pital to hospital comparison: number of utilized grams, number
of utilized DDD’s, number of grams utilized per 100 bed-days
and ﬁnally the number of DDD’s per 100 bed-days. Additional
analysis of each hospital’s treatment guidelines was performed
for those ATC classes having actual treatment guidelines and
results assessed in light of the level of implementation effective-
ness and impact on the cost and bacterial resistance rate.
RESULTS: Differences in antibacterial use between two leading
University Hospitals in Croatia and Bosnia and Herzegovina
were noted. Of all noted differences two classes of antibiotics
were further analyzed because of their well known impact on
bacterial resistance: third generation cephalosporins and quino-
lones. Subsequent analysis of the incidence of MRSA infections
and Gram negative ESBL bacteria are conclusive and in line with
the reported utilization ﬁndings. CONCLUSIONS: Although
some treatment guidelines for antibacterial prophylaxis and
treatment of bacterial infections were effectively implemented in
both hospitals, there were still those which have to be developed
and/or revised and subsequently implemented in order to ensure
the most beneﬁcial cost-effectiveness ratio and positive impact on
bacterial resistance. Additional intra-hospital measures are to be
developed and implemented in order to ensure the compliance
with treatment guidelines, such as internal audits and issue-
focused education of relevant health care professionals.
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OBJECTIVES: Intravenous (IV) to oral (PO) switch therapy is a
demonstrated method to achieve a more rational use of antibi-
otics. Several advantages have been associated with this strategy
such as less preparation time, easier administration, greater
comfort, lower risk of complications and lower antibiotic
budget. The objective was to evaluate the impact of promoting
an IV to PO switch of ﬂuoroquinolones (FQ) with three different
educational interventions. METHODS: A prospective observa-
tional study was conducted in 16 different wards of a teaching
hospital of 959 beds. For all patients treated with a FQ, what-
ever the site of infection, data related to infection and therapy
were collected during four different 3-month periods. The ﬁrst
period (A) was observational without intervention to identify
the prescription habits. The second period (B) was a period of
“passive” intervention with publication of IV/PO switch criteria
in the hospital bulletin and personal letter to each physician. The
third and fourth periods C and D were two crossover active
interventions: intervention 1) IV/PO switch training sessions by
clinical pharmacist to all physicians of the selected wards, and
intervention 2) proactive interventions by clinical pharmacist.
RESULTS: A total of 349 prescriptions were recorded. There
was a signiﬁcant reduction in number of overprescription days
of IV treatment during period B compared to period A
(4.6  0.5 and 3.1  0.4, p = 0.027) and period B compared to
periods C + D (3.1  0.4 and 1.5  0.2, p < 0.001). Antibiotics
budget and number of FQ vials were also reduced. There was no
statistical difference between the two different active interven-
tions (p = 0.82). CONCLUSIONS: Passive and active interven-
tions to teach early switch from IV to PO FQ therapy are highly
effective (p < 0.05). Active intervention by a clinical pharmacist
whatever it is team-focused or case-focused is more efﬁcient than
passive.
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OBJECTIVES: To evaluate vaccination policies for meningococ-
cal disease in the US, we adapted and calibrated a dynamic model
of meningococcal disease originally developed for the UK.
METHODS: We adapted an age-stratiﬁed mathematical model
of meningococcal transmission, carriage, and disease from the
UK to the US setting. The model focus was expanded from
serogroup C to serogroups A, C, W, and Y disease to reﬂect
newer vaccines. The most recent available US cross-sectional
carriage data were used to extract serogroups A, W, and Y
carriage from the non-C (“other”) serogroup data used in the UK
model. We used recently-published contact matrix data for trans-
mission calculations and performed formal calibrations to pub-
lished US surveillance data. We ﬁrst calibrated age-speciﬁc force
of infection to ACWY carriage data and solved for transmission
rates (b) at equilibrium for a cohort of 75,000 individuals rep-
resentative of the US population. We then calibrated the risk of
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